European Urology

Viewing slides 1-6 of 6

• S0302-2838(12)01423-6.title drag remove slide sort drag into slide Title Complications and Early Postoperative Outcome in 1080 Patients After Thulium Vapoenucleation of the Prostate: Results at a Single Institution
  
  Andreas J. Gross, Christopher Netsch, Sophie Knipper, ... Complications and Early Postoperative Outcome in 1080 Patients After Thulium Vapoenucleation of the ... Zoom
• S0302-2838(12)01423-6.introduction drag remove slide sort drag into slide Introduction • Thulium VapoEnucleation of the prostate (ThuVEP) has been introduced as a minimally-invasive treatment for benign prostatic obstruction (BPO).
  
  • We report standardized perioperative ... • Thulium VapoEnucleation of the prostate (ThuVEP) has been introduced as a minimally-invasive ... Zoom
• 23998 drag remove slide sort drag into slide A significant decrease in Clavien 3b complications between the first and the ... Zoom read this article »
• S0302-2838(12)01423-6.materials_and_methods drag remove slide sort drag into slide Materials and methods • 1080 patients underwent ThuVEP at a single institution.
  
  • ThuVEP was performed using a 2 µm continuous wave Tm:YAG laser.
  
  • Preoperative status, surgical details, and ... • 1080 patients underwent ThuVEP at a single institution. • ThuVEP was performed ... Zoom
• S0302-2838(12)01423-6.results drag remove slide sort drag into slide Results • Median prostate size was 51 ml; Median catheter time was 2, and hospital stay was 4 days.
  
  • At discharge, median maximum urinary flow rate (8.9 vs. 18.4 ml/s) and post-voiding residual ... • Median prostate size was 51 ml; Median catheter time was 2, and hospital stay was 4 ... Zoom
• S0302-2838(12)01423-6.conclusion drag remove slide sort drag into slide Conclusion • ThuVEP is a safe and effective procedure for the treatment of symptomatic BPO with low perioperative morbidity. • ThuVEP is a safe and effective procedure for the treatment of symptomatic BPO with low ... Zoom

Viewing slides 1-6 of 6